|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
5/17/2013
|
Bujarski Robert Joseph
|
SVP, Bus Dev & Gen Counsel
|
19,196
|
$8.50
|
38.27%
|
|
5/17/2013
|
Bujarski Robert Joseph
|
SVP, Bus Dev & Gen Counsel
|
-19,196
|
$23.02
|
-27.68%
|
|
5/15/2013
|
Bujarski Robert Joseph
|
SVP, Bus Dev & Gen Counsel
|
-8,283
|
$23.35
|
-14.17%
|
|
5/15/2013
|
Bujarski Robert Joseph
|
SVP, Bus Dev & Gen Counsel
|
8,283
|
$8.50
|
16.51%
|
|
4/10/2013
|
Bujarski Robert Joseph
|
SVP, Bus Dev & Gen Counsel
|
-3,181
|
$22.60
|
-5.96%
|
|
2/28/2013
|
TAMERIUS JOHN
|
SVP - Clinical/Reg Affairs
|
11,719
|
$7.50
|
41.01%
|
|
2/28/2013
|
TAMERIUS JOHN
|
SVP - Clinical/Reg Affairs
|
17,133
|
$8.50
|
42.52%
|
|
2/2/2013
|
BRYANT DOUGLAS C
|
President & CEO
|
-13,331
|
$22.70
|
-6.65%
|
|
1/18/2013
|
McLeod Scot M
|
SVP - Operations
|
-927
|
$21.36
|
-2.62%
|
|
1/18/2013
|
Stenzel Timothy Todd
|
Chief Science Officer
|
-1,022
|
$21.36
|
-5.78%
|
|
1/18/2013
|
Bujarski Robert Joseph
|
SVP, General Counsel & Secy
|
-1,151
|
$21.36
|
-2.11%
|
|
1/18/2013
|
TAMERIUS JOHN
|
SVP - Clinical/Reg Affairs
|
-943
|
$21.36
|
-1.70%
|
|
1/18/2013
|
BRYANT DOUGLAS C
|
President & CEO
|
-3,681
|
$21.36
|
-1.80%
|
|
1/18/2013
|
BRYANT DOUGLAS C
|
President & CEO
|
-6,442
|
$21.36
|
-3.16%
|
|
1/18/2013
|
Stenzel Timothy Todd
|
Chief Science Officer
|
-2,331
|
$21.36
|
-12.27%
|
|
1/18/2013
|
McLeod Scot M
|
SVP - Operations
|
-2,114
|
$21.36
|
-5.78%
|
|
1/18/2013
|
Bujarski Robert Joseph
|
SVP, General Counsel & Secy
|
-2,356
|
$21.36
|
-4.23%
|
|
1/18/2013
|
TAMERIUS JOHN
|
SVP - Clinical/Reg Affairs
|
-2,151
|
$21.36
|
-3.79%
|
|
12/7/2012
|
TAMERIUS JOHN
|
SVP - Clinical/Reg Affairs
|
9,000
|
$3.19
|
21.32%
|
|
12/6/2012
|
POLAN MARY LAKE PH D
|
Director
|
12,750
|
$5.44
|
72.73%
|
|
12/6/2012
|
POLAN MARY LAKE PH D
|
Director
|
9,331
|
$9.93
|
30.82%
|
|
12/4/2012
|
TAMERIUS JOHN
|
SVP - Clinical/Reg Affairs
|
-4,000
|
$18.23
|
-8.66%
|
|
11/29/2012
|
Brown Thomas D
|
Director
|
5,331
|
$9.93
|
28.21%
|
|
11/29/2012
|
Brown Thomas D
|
Director
|
-5,331
|
$17.31
|
-22.00%
|
|
11/27/2012
|
Brown Thomas D
|
Director
|
-4,000
|
$17.31
|
-17.47%
|
|
11/27/2012
|
Brown Thomas D
|
Director
|
4,000
|
$9.93
|
21.17%
|
|
5/3/2012
|
BRYANT DOUGLAS C
|
President & CEO
|
10,000
|
$15.78
|
5.15%
|
|
3/21/2012
|
SCHULER JACK W
|
Director
|
40,000
|
$16.65
|
1.22%
|
|
3/20/2012
|
SCHULER JACK W
|
Director
|
15,815
|
$16.48
|
0.49%
|
|
3/19/2012
|
BRYANT DOUGLAS C
|
President & CEO
|
10,000
|
$16.55
|
5.43%
|
|
3/19/2012
|
SCHULER JACK W
|
Director
|
10,000
|
$16.60
|
0.31%
|
|
3/15/2012
|
TAMERIUS JOHN
|
SVP - Clinical/Reg Affairs
|
-2,700
|
$16.15
|
-5.52%
|
|
3/15/2012
|
TAMERIUS JOHN
|
SVP - Clinical/Reg Affairs
|
-800
|
$16.18
|
-1.61%
|
|
3/9/2012
|
Brown Thomas D
|
Director
|
-5,482
|
$16.13
|
-28.39%
|
|
3/9/2012
|
Brown Thomas D
|
Director
|
5,482
|
$5.59
|
39.64%
|
|
3/5/2012
|
POLAN MARY LAKE PH D
|
Director
|
2,000
|
$15.12
|
13.40%
|
|
2/21/2012
|
TAMERIUS JOHN
|
SVP - Clinical/Reg Affairs
|
5,625
|
$5.70
|
14.50%
|
|
2/2/2012
|
BRYANT DOUGLAS C
|
President & CEO
|
-9,163
|
$14.51
|
-4.74%
|
|
1/18/2012
|
BRYANT DOUGLAS C
|
President & CEO
|
-5,028
|
$15.14
|
-2.54%
|
|
10/26/2011
|
PULIDO MARK
|
Director
|
10,000
|
$5.45
|
53.59%
|
|
10/26/2011
|
PULIDO MARK
|
Director
|
3,730
|
$5.08
|
24.98%
|
|
10/26/2011
|
PULIDO MARK
|
Director
|
-13,730
|
$17.09
|
-47.91%
|
|
10/7/2011
|
PULIDO MARK
|
Director
|
-10,670
|
$17.04
|
-41.68%
|
|
10/7/2011
|
PULIDO MARK
|
Director
|
10,670
|
$5.08
|
71.47%
|
|
10/6/2011
|
PULIDO MARK
|
Director
|
-17,000
|
$17.03
|
-53.24%
|
|
10/6/2011
|
PULIDO MARK
|
Director
|
17,000
|
$5.08
|
113.86%
|
|
10/5/2011
|
PULIDO MARK
|
Director
|
-8,600
|
$17.02
|
-36.55%
|
|
10/5/2011
|
PULIDO MARK
|
Director
|
8,600
|
$5.08
|
57.60%
|
|
8/9/2011
|
TAMERIUS JOHN
|
SVP - Clinical/Reg Affairs
|
500
|
$13.25
|
1.31%
|
|
8/9/2011
|
TAMERIUS JOHN
|
SVP - Clinical/Reg Affairs
|
50
|
$13.25
|
0.13%
|
|
8/9/2011
|
TAMERIUS JOHN
|
SVP - Clinical/Reg Affairs
|
200
|
$13.25
|
0.53%
|
|
8/8/2011
|
SCHULER JACK W
|
Director
|
79,135
|
$14.00
|
2.50%
|
|
8/5/2011
|
BRYANT DOUGLAS C
|
President & CEO
|
20,000
|
$13.89
|
11.47%
|
|
8/5/2011
|
SCHULER JACK W
|
Director
|
20,865
|
$14.07
|
0.66%
|
|
6/9/2011
|
Bujarski Robert Joseph
|
SVP, General Counsel & Secy
|
-20,992
|
$15.45
|
-27.10%
|
|
6/8/2011
|
BRYANT DOUGLAS C
|
President & CEO
|
5,000
|
$15.18
|
2.95%
|
|
6/7/2011
|
BRYANT DOUGLAS C
|
President & CEO
|
5,000
|
$14.96
|
3.04%
|
|
5/5/2011
|
SCHULER JACK W
|
Director
|
409
|
$13.66
|
0.01%
|
|
5/5/2011
|
BRYANT DOUGLAS C
|
President & CEO
|
900
|
$13.49
|
0.55%
|
|
5/3/2011
|
BRYANT DOUGLAS C
|
President & CEO
|
900
|
$13.05
|
0.56%
|
|
5/3/2011
|
BRYANT DOUGLAS C
|
President & CEO
|
500
|
$13.11
|
0.31%
|
|
5/3/2011
|
BRYANT DOUGLAS C
|
President & CEO
|
100
|
$13.10
|
0.06%
|
|
5/3/2011
|
BRYANT DOUGLAS C
|
President & CEO
|
1,000
|
$13.06
|
0.62%
|
|
5/3/2011
|
SCHULER JACK W
|
Director
|
4,591
|
$13.01
|
0.15%
|
|
2/2/2011
|
BRYANT DOUGLAS C
|
President & CEO
|
-10,212
|
$13.90
|
-5.96%
|
|
1/11/2011
|
SCHULER JACK W
|
Director
|
475,000
|
$13.15
|
17.81%
|
|
1/3/2011
|
McLeod Scot M
|
SVP - Operations
|
-1,674
|
$14.74
|
-4.31%
|
|
1/3/2011
|
BRYANT DOUGLAS C
|
President & CEO
|
-2,440
|
$14.74
|
-1.41%
|
|
1/3/2011
|
Bujarski Robert Joseph
|
SVP, General Counsel & Secy
|
-588
|
$14.74
|
-0.75%
|
|
1/3/2011
|
RADAK JOHN MATTHEW
|
Chief Financial Officer
|
-62
|
$14.74
|
-0.30%
|